Konferenzschrift
Targeted therapies for neurodevelopmental disorders : model systems, disease mechanisms, and novel approaches
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783318069600
- Maße
-
28 cm
- Umfang
-
Seite 140-261
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen
- Erschienen in
-
Developmental neuroscience ; vol. 43, no. 3/4 (2021)
- Schlagwort
-
Nervenkrankheit
Entwicklungsstörung
Therapie
- Ereignis
-
Veröffentlichung
- (wo)
-
Basel, Freiburg
- (wer)
-
Karger
- (wann)
-
[2021]
- Beteiligte Personen und Organisationen
-
Goldberg, Ethan M.
Tzingounis, Anastasios V.
Towards Targeted Therapy for Neurodevelopmental Disorders Symposium (2020 : Online)
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Konferenzschrift
Beteiligte
- Goldberg, Ethan M.
- Tzingounis, Anastasios V.
- Towards Targeted Therapy for Neurodevelopmental Disorders Symposium (2020 : Online)
- Karger
Entstanden
- [2021]
Ähnliche Objekte (12)
Neuroimmunomodulation in neurodevelopmental disorders
The Epigenome in Neurodevelopmental Disorders
Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Presynaptic dysfunction in CASK-related neurodevelopmental disorders
Neurobiological mechanisms of reward processing in neurodevelopmental disorders: a multi-methodological and transdiagnostic approach
The role of RNA binding proteins in neurodevelopmental disorders
Impact of clinical exomes in neurodevelopmental and neurometabolic disorders
Developing targeted therapies for pediatric PFA ependymoma
Neuroprotection : models, mechanisms and therapies
The role of MYT1L in the aetiology of neurodevelopmental disorders
Review of neurodevelopmental disorders in patients with HNF1B gene variations
Neuroimmunomodulation in neurodevelopmental disorders
The Epigenome in Neurodevelopmental Disorders
Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Presynaptic dysfunction in CASK-related neurodevelopmental disorders
Neurobiological mechanisms of reward processing in neurodevelopmental disorders: a multi-methodological and transdiagnostic approach
The role of RNA binding proteins in neurodevelopmental disorders
Impact of clinical exomes in neurodevelopmental and neurometabolic disorders
Developing targeted therapies for pediatric PFA ependymoma
Neuroprotection : models, mechanisms and therapies
The role of MYT1L in the aetiology of neurodevelopmental disorders
Review of neurodevelopmental disorders in patients with HNF1B gene variations
Neuroimmunomodulation in neurodevelopmental disorders
The Epigenome in Neurodevelopmental Disorders
Molecular mechanisms of PI3K/mTOR-targeted therapies in hepatocellular carcinoma
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Presynaptic dysfunction in CASK-related neurodevelopmental disorders
Neurobiological mechanisms of reward processing in neurodevelopmental disorders: a multi-methodological and transdiagnostic approach
The role of RNA binding proteins in neurodevelopmental disorders
Impact of clinical exomes in neurodevelopmental and neurometabolic disorders
Developing targeted therapies for pediatric PFA ependymoma
Neuroprotection : models, mechanisms and therapies
The role of MYT1L in the aetiology of neurodevelopmental disorders